Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Targeting the skin's endocannabinoid system could help treat skin disorders.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Testosterone may slow down wound healing and increase inflammation.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.